Position in ZTS
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$22,030,551
-$19,237,151 QoQ
Shares Held
306,576
-12.2% QoQ
Ownership
0.074%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#150
of 1,408 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026BI Asset Management Fondsmaeglerselskab A/S holds $42,638,294 across 9 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (51.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
This page
|
306,576 | $22,030,551 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
12,597 | $6,825,432 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
33,211 | $5,597,381 | |
| 4 | VTRS |
Viatris Inc
|
150,504 | $2,390,003 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
90,865 | $2,236,187 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
54,001 | $1,829,553 | |
| 7 | INDV |
Indivior Pharmaceuticals, Inc.
|
39,832 | $1,634,306 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
544 | $60,351 |
All Filings in ZTS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $22,030,551 | 306,576 | Shares | Defined | 2026-08-10 | |
| 2026-03-31 | $41,267,702 | 349,105 | Shares | Defined | 2026-04-16 | |
| 2025-12-31 | $34,245,687 | 272,180 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $54,744,603 | 374,143 | Shares | Defined | 2025-11-05 | |
| 2025-06-30 | $57,241,759 | 367,052 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $31,642,107 | 192,178 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $45,899,824 | 281,715 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $6,470,985 | 33,120 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $4,209,874 | 24,284 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $7,095,144 | 41,931 | Shares | Defined | 2024-05-03 | |
| 2023-12-31 | $5,218,462 | 26,440 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $3,430,711 | 19,719 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $4,185,564 | 24,305 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $2,776,552 | 16,682 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $2,376,161 | 16,214 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,169,266 | 7,885 | Shares | Defined | 2022-11-07 | |
| 2022-06-30 | $1,453,501 | 8,456 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $648,372 | 3,438 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $1,048,840 | 4,298 | Shares | Defined | 2022-02-02 | |
| 2021-09-30 | $834,413 | 4,298 | Shares | Defined | 2021-11-09 | |
| 2021-06-30 | $1,195,499 | 6,415 | Shares | Defined | 2021-08-06 | |
| 2021-03-31 | $1,010,234 | 6,415 | Shares | Defined | 2021-05-10 | |
| 2020-12-31 | $4,513,350 | 27,271 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $3,534,618 | 21,374 | Shares | Defined | 2020-11-09 | |
| 2020-06-30 | $2,700,647 | 19,707 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $1,729,101 | 14,692 | Shares | Defined | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||